The timing of the study could hardly be more consequential. Managing authorities in Norway and Sweden have decided to reduce the Scandinavian wolf population to approximately 170 individuals, a census size they consider sustainable. That decision rests in part on recent population viability analyses commissioned by the same authorities, which concluded that a population of this magnitude could maintain its genetic viability. The new pedigree-based analysis directly challenges those conclusions, questioning whether the scientific foundation for the cull quotas is sound.

At the heart of the study is a concept that conservation biologists regard as perhaps the single most important number in population genetics: the effective population size, abbreviated Ne. Unlike the census count of animals, the effective size captures how many individuals would be needed in an idealized population to produce the same rate of genetic drift, inbreeding, and loss of diversity as the real population actually experiences. In practice, Ne is almost always far smaller than the raw headcount, because not every animal breeds, sex ratios are rarely balanced, and reproductive success is unevenly distributed. The effective size determines the pace at which genetic diversity erodes and inbreeding accumulates, and it therefore governs both short-term extinction risk through inbreeding depression and long-term viability through the loss of adaptive potential.

What makes the new analysis unusually powerful is the quality of the underlying data. Since the Scandinavian wolf population was re-established by a handful of founders, researchers have meticulously reconstructed its complete pedigree, drawing on decades of field monitoring, DNA sampling, and individual identification. Raw source data drawn from the pedigree compilation published by Åkesson and colleagues in 2023 allowed the team to calculate Ne precisely for every year since the population’s founding, using four-year cohorts along a one-year moving window. Rather than inferring genetic health from statistical snapshots of DNA samples, the researchers could trace the actual reproductive paths of every known animal, an approach that removes much of the uncertainty that plagues conventional genetic estimates.

The results reveal a population whose effective size has remained persistently and critically low throughout its history. The Scandinavian population was founded by only a few individuals and, despite growing to several hundred animals in census terms, has never achieved an effective size compatible with widely accepted conservation genetic benchmarks. The population’s history includes a well-documented severe inbreeding depression episode in the late 1990s and early 2000s, when pups from closely related pairs suffered dramatically reduced survival, and a partial genetic rescue delivered by a single immigrant male from the Finnish-Russian population. Subsequent work has documented the genomic consequences of this intensive inbreeding, including elevated levels of harmful homozygosity across the genome.

The study also scrutinizes the assumptions of the recent simulation studies that inform current management, including minimum viable population analyses prepared for the Swedish Environmental Protection Agency. According to Mergeay and colleagues, those simulations greatly overestimate the effective size of the Scandinavian wolf population, likely because they fail to adequately account for the population’s peculiar and well-documented reproductive structure. Wolves live in territorial packs in which typically only the dominant pair breeds, a social system that dramatically inflates the gap between census numbers and effective size. When this mating structure is properly represented, the same census count translates into a far smaller effective population than the commissioned analyses assumed, and the projected timelines for inbreeding and diversity loss become correspondingly more alarming.

The implications reach beyond Scandinavia. Conservation genetics has long relied on rules of thumb, notably the 50/500 rule, which suggests that an effective size of at least 50 is needed to avoid short-term inbreeding depression and 500 to retain long-term evolutionary potential, with revised recommendations pushing the long-term figure considerably higher. A population managed at a census size of roughly 170 animals, with a pack structure that suppresses Ne far below the census count, falls short of these benchmarks by a wide margin. The findings echo warnings issued in 2022 in the journal Science, when prominent conservation geneticists argued that planned culls would endanger the Swedish wolf population, and they align with a growing body of evidence from other inbred wolf populations, including the famously inbred wolves of Isle Royale, where genetic erosion contributed to a population crash.

The study arrives amid a charged political and legal debate over wolf management in Europe. Wolf culling policies in both Norway and Sweden have drawn formal complaints under the Bern Convention on the conservation of European wildlife and natural habitats, and the European Court of Justice has recently clarified the legal yardstick of favourable conservation status in a wave of wolf-related cases. Under the EU Habitats Directive, member states must maintain populations at a status where they can thrive long term without being dependent on continued conservation measures, a standard that inherently involves genetic considerations. If the effective size of the Scandinavian population is genuinely too small for long-term persistence, the legal and scientific case for reducing it further becomes considerably harder to defend.

The authors emphasize that their findings do not merely refine an academic parameter; they strike at the usefulness of the very models being used to set quotas. If simulation studies overestimate Ne, they will systematically underestimate the rate of inbreeding and the speed of diversity loss, producing optimistic projections of viability that the real population cannot match. The researchers suggest that management informed by these flawed models risks steering the population into an extinction vortex, in which shrinking numbers accelerate inbreeding, inbreeding depresses survival and reproduction, and the resulting decline further shrinks the population. Recent theoretical work suggests such vortices can be driven as much by a shortage of beneficial mutations as by the accumulation of harmful ones, underscoring how difficult a genetically impoverished population is to rescue once diversity is gone.

For the Scandinavian wolf, the path forward suggested by the genetics is clear even if politically difficult: either the population must be allowed to grow substantially, or gene flow from the larger Finnish-Russian wolf population must be facilitated at a rate sufficient to counteract drift and inbreeding. The one-migrant-per-generation rule, long a staple of conservation genetics, may need to be exceeded in this case given the population’s extreme isolation and skewed reproductive structure. What the new study makes unmistakable is that the current management trajectory, a population capped at 170 animals justified by models that overestimate its genetic buffer, is incompatible with the population’s own pedigree. As the authorities finalize their reduction plans, they will have to reckon with a complete, individual-level record of every wolf that has lived in Scandinavia, and that record tells a story of a population living dangerously close to its genetic limits.

Subject of Research: Effective population size and genetic viability of the Scandinavian wolf population

Article Title: The effective size of the Scandinavian wolf population is too small for both short- and long-term conservation

Article References: Mergeay, J., Flagstad, Ø., & Waples, R. S. (2026). The effective size of the Scandinavian wolf population is too small for both short- and long-term conservation. Heredity. https://doi.org/10.1038/s41437-026-00877-y

Image Credits: AI Generated

DOI: 10.1038/s41437-026-00877-y

Keywords: Scandinavian wolf population, effective population size, inbreeding, conservation genetics, population viability analysis, genetic drift, wolf culling, pedigree analysis, Heredity, large carnivore management, genetic rescue, extinction risk

The review, authored by Giulio Caravagna of the University of Trieste and Area Science Park, Trevor A. Graham of the Centre for Evolution and Cancer at The Institute of Cancer Research in London, and Andrea Sottoriva of Human Technopole in Milan, makes a deceptively simple but profound point. Sequencing is a snapshot, whereas evolution is a dynamic process. A single tumour biopsy tells us which mutations are present and at what frequencies, but it does not, by itself, reveal the underlying dynamics that produced them. Bridging this gap requires models. Population genetics, the discipline developed over the past century to understand how allele frequencies change in natural populations under the influence of mutation, selection and drift, provides exactly the framework needed to transform static measurements of variant allele frequencies into quantitative estimates of clonal fitness and evolutionary timings.

At the heart of the framework lies the concept of the site frequency spectrum, the distribution of mutations across different variant allele frequencies within a tumour sample. In a neutrally evolving tumour, one in which no clone enjoys a fitness advantage over its neighbours, mathematical theory predicts a characteristic power-law tail: a predictable excess of mutations at progressively lower frequencies, each arising in expanding lineages as passengers hitchhiking along with the growing clone. This ‘neutral tail’ has become a signature of neutral tumour evolution, first identified across cancer types in work led by the same research groups. Deviations from this expected distribution are the fingerprints of selection. When subclones carrying driver mutations expand faster than neutral expectations, the frequency spectrum distorts in characteristic and quantifiable ways, allowing researchers to estimate the strength of selection rather than merely guess at it.

The authors show how modern computational tools exploit these principles. Subclonal deconvolution, the process of resolving a bulk sequencing sample into its constituent clonal and subclonal populations, has traditionally been treated as a clustering problem. But clustering alone cannot distinguish between a tumour shaped by strong selection and one dominated by spatially constrained growth, where genetic diversity accumulates by neutral drift in separate geographic compartments. By embedding population genetic models directly into inference algorithms, for example approaches combining machine learning with branching process theory, researchers can distinguish genuine selection from the illusions created by tumour architecture and sampling bias. Simulations of mutation, drift and selection can be tuned until the synthetic genomic data they produce match patient samples, converting descriptive allele frequencies into estimates of evolutionary parameters such as selection coefficients and the timing of clonal expansions.

Timing is one of the most clinically valuable outputs of this framework. Clock-like mutational processes, such as the spontaneous deamination of methylated cytosines, accumulate at approximately constant rates, providing a molecular clock against which key events can be dated. Studies of clear cell renal cell cancer have used these principles to time landmark events in tumour evolution, revealing that many chromosomal catastrophes occur astonishingly early, sometimes decades before diagnosis. More recent theoretical work has shown that patient age itself can help distinguish selection from causation in cancer genomes, since a mutation that arises early and confers a growth advantage leaves a different statistical imprint than one that simply accumulates with time. Dating driver events, genome doublings and the origins of metastatic seeds transforms the tumour genome from a parts list into a chronicle.

The review also confronts the limitations and confounders that complicate evolutionary inference from real data. Bulk sequencing averages across millions of cells, obscuring rare subclones and entangling spatial structure with temporal dynamics. Multi-region sequencing and single-cell approaches help, but each introduces its own biases: sampling depth, copy number alterations that distort allele frequencies, and the fundamental fact that a biopsy represents only a fragment of a spatially extended population. Copy number changes in particular must be carefully modelled, since amplifications and deletions shift variant allele frequencies in ways that can mimic or mask selection. The authors emphasise that assumptions embedded in population genetic models, such as well-mixed populations or constant growth rates, must be tested rather than taken for granted, because spatially constrained tumour growth can generate patterns that superficially resemble selection in the absence of any fitness advantage.

Beyond genetics, the framework extends to epigenetic inheritance and phenotypic plasticity, two dimensions of cancer evolution that the standard genetic models handle poorly. Epigenetic states such as DNA methylation patterns are heritable across cell divisions and can be under selection, yet they are reversible and can switch stochastically, creating a one-to-many relationship between genotype and phenotype. Quantitative models adapted from evolutionary theory, including those describing phenotypic plasticity and stochastic switching in fluctuating environments, offer a way to measure the heritability, transition rates and fitness consequences of non-genetic states. This matters enormously for therapy, because drug-tolerant persister cells frequently arise through epigenetic reprogramming rather than genetic mutation, and their dynamics determine whether resistance emerges in weeks or years.

The ecological dimension of tumour evolution receives similar treatment. Cancers are not just populations of competing clones; they are ecosystems in which cells cooperate, cheat and interact with stromal and immune cells. Game theory and eco-evolutionary models capture frequency-dependent selection, in which the fitness of a clone depends on the composition of its neighbourhood, something classical population genetics assumes away. These models have practical consequences. Adaptive therapy strategies, which aim to maintain sensitive clones that suppress resistant ones rather than eradicate the tumour wholesale, draw directly on ecological and game-theoretic reasoning. Similarly, immune selection on neoantigens shapes both tumour antigenicity and response to checkpoint inhibitors, and can be quantified using selection metrics adapted from population genetics.

Ultimately, the review’s central message is one of reframing. Cancer genomes should be read not as catalogues of mutations but as quantitative records of evolutionary processes, in which every allele frequency, every frequency-spectrum distortion and every signature of mutational timing encodes information about the dynamics that produced them. The authors argue that population genetics provides the foundation for understanding and, ultimately, predicting the trajectories of cancer evolution. If the framework fulfils its promise, the implications for precision oncology are substantial: forecasts of relapse timing grounded in measured evolutionary parameters, treatment strategies designed around the predictable dynamics of resistance, and clinical decisions informed not merely by which mutations a tumour carries today, but by the evolutionary forces that will shape what it becomes tomorrow.

The intellectual roots of this framework stretch well beyond oncology. Population genetics matured through the study of natural populations, and its migration into cancer research has been gradual, beginning with early attempts to reconstruct individual tumour histories from genetic data and gaining momentum as sequencing costs fell. A parallel body of work on clonal haematopoiesis and on pre-malignant lesions in normal tissues has reinforced the point that the evolutionary processes described in the review operate long before a tumour is diagnosed. Studies of normal breast tissue, for example, have revealed rare aneuploid epithelial populations and copy number alterations shared with frank cancers, suggesting that the same population genetic tools can illuminate the earliest steps of carcinogenesis across a continuous spectrum from healthy tissue to invasive disease.

Selection in tumours is not exclusively positive. Adapted metrics such as the ratio of synonymous to non-synonymous mutations, borrowed directly from classical genetics, have revealed universal patterns of selection in cancer and somatic tissues, while complementary analyses indicate that negative selection acts on essential cellular functions and on the immunopeptidome, pruning mutations that would compromise basic biology or expose cells to immune attack. Copy number amplifications of wild-type regions may further allow tumours to tolerate otherwise deleterious coding mutations, a reminder that the interplay between different classes of genomic alteration can obscure simple fitness calculations. At population scale, large studies of somatic mutation across many individuals now provide the statistical power to measure these forces with unprecedented precision.

Practical questions of study design also fall within the framework’s remit. How many biopsies are needed to confidently identify truly clonal mutations in a heterogeneous tumour, and how sampling schemes affect the inferred frequency spectrum, are problems that can themselves be solved with evolutionary models rather than ad hoc rules. The review’s figures trace this progression, from conceptual overviews of genomic readouts through the dynamics of variant allele frequencies, the confounding effects of spatial structure, and the distinct evolutionary routes by which tumours respond to therapy and relapse. Together they map a research programme in which the reliability of every evolutionary claim is tied explicitly to the sampling strategy and the model assumptions behind it.

Subject of Research: Application of population genetics models to infer tumour evolutionary dynamics from cancer genome sequencing data.

Article Title: A guide to understanding tumour evolution through the lens of population genetics

Article References: Caravagna, G., Graham, T. A., & Sottoriva, A. (2026). A guide to understanding tumour evolution through the lens of population genetics. Nature Reviews Cancer. https://doi.org/10.1038/s41568-026-00973-5

Image Credits: AI Generated

DOI: 10.1038/s41568-026-00973-5

Keywords: tumour evolution, population genetics, cancer genomics, clonal selection, variant allele frequency, subclonal deconvolution, genetic drift, mutational signatures, phenotypic plasticity, adaptive therapy, tumour heterogeneity, molecular clock